IPSEN Scandinavia A/S

Nordic affiliate of Ipsen, the French biopharmaceutical company founded in 1929 and headquartered in Paris, covering Denmark, Sweden, Norway, Finland and Iceland from its office in Copenhagen. Markets Ipsen's oncology, neuroscience and rare disease medicines in the region, including somatostatin analogues for neuroendocrine tumours, botulinum toxin for neurological indications and treatments for liver and bone disease, and runs regional medical affairs, regulatory work and clinical trials.